L Vilar, CF Vilar, R Lyra, MC Freitas - Neuroendocrinology, 2019 - karger.com
An appropriate diagnostic evaluation is essential for the most appropriate treatment to be performed. Currently, macroprolactinemia is the third most frequent cause of …
Early diagnosis of Parkinson's disease and hyperprolactinemia based on electrochemical dopamine (DA) sensing appears as an efficient and promising practical diagnostic method …
Около 70% всех гинекологических заболеваний гормонально детерминированы. Тактика ведения таких пациенток требует от клинициста знаний основ эндокринологии …
Hyperprolactinemia (hPRL) often poses a diagnostic dilemma due to the presence of macroprolactin. Understanding the prevalence of macroprolactinemia (mPRL) has an …
This paper reviews the prevalence, implications, prevention and management of antipsychotic-induced hyperprolactinemia in aging populations. Antipsychotics are indicated …
E Eren, AT Ergür, ŞP İşgüven, EÇ Bitkin… - Journal of clinical …, 2019 - jag.journalagent.com
Objective: We aimed to report the characteristics at admission, diagnosis, treatment, and follow-up of cases of pediatric hyperprolactinemia in a large multicenter study. Methods: We …
V Borba, P Carrera-Bastos, G Zandman-Goddard… - Autoimmunity …, 2024 - Elsevier
Over 100 diseases have been recognized as autoimmune in nature, collectively affecting~ 20% of the population in industrialized countries. These conditions are more prevalent …
R Krysiak, K Kowalcze… - Journal of Clinical …, 2021 - Wiley Online Library
What is known and objective Metformin‐induced reduction in prolactin levels is more pronounced in users of hormonal contraception than in non‐users. The current study was …
M Šostarić, A Bokulić, D Marijančević, I Zec - Biochemia medica, 2019 - hrcak.srce.hr
Original articles Page 1 https://doi.org/10.11613/BM.2019.020706 Biochem Med (Zagreb) 2019;29(2):020706 G1 Abstract Introduction: Macroprolactinaemia is a well-known analytical …